Qlaris Bio

Provides AI-based technology for treating ophthalmic diseases

placeNew York, United States calendar_todayFounded 2019 groups9 employees language qlaris.bio

Innovation

4 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 412 times.

YearFilings
20212
20222
20231
20244
20253
20261

Social engagement

Social engagement: 1.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Canaan, New Leaf Venture Partners.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Recent activity

8 May 2026
Event
ARVO meeting
6 Apr 2026
Event
CMOSummit360
31 Mar 2026
Leadership hire
Senior Vice President of Strategy and Corporate Development
Coming soon